PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power.
PITX1
biomarkers
mixed integer linear programming
modularity
prostate cancer
regulatory networks
transcription factors
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
01 Mar 2022
01 Mar 2022
Historique:
received:
11
01
2022
revised:
23
02
2022
accepted:
24
02
2022
entrez:
10
3
2022
pubmed:
11
3
2022
medline:
11
3
2022
Statut:
epublish
Résumé
The current risk stratification in prostate cancer (PCa) is frequently insufficient to adequately predict disease development and outcome. One hallmark of cancer is telomere maintenance. For telomere maintenance, PCa cells exclusively employ telomerase, making it essential for this cancer entity. However, TERT, the catalytic protein component of the reverse transcriptase telomerase, itself does not suit as a prognostic marker for prostate cancer as it is rather low expressed. We investigated if, instead of
Identifiants
pubmed: 35267575
pii: cancers14051267
doi: 10.3390/cancers14051267
pmc: PMC8909694
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Federal Ministry of Education and Research
ID : 01ZX1302B, 01ZX1602B, 01EO1002, 01EO1502
Références
Methods Mol Biol. 2010;664:37-44
pubmed: 20690050
Tumour Biol. 2015 Sep;36(10):7735-41
pubmed: 25936343
Nucleic Acids Res. 2014 May;42(9):e75
pubmed: 24609383
Cancer Res. 2013 May 1;73(9):2795-805
pubmed: 23492366
BMC Bioinformatics. 2019 Dec 30;20(1):737
pubmed: 31888467
Carcinogenesis. 2010 Jan;31(1):9-18
pubmed: 19887512
IEEE Trans Med Imaging. 2010 Aug;29(8):1474-84
pubmed: 20562043
Mol Cell Biol. 2011 Apr;31(8):1624-36
pubmed: 21300782
Eur Urol. 2018 May;73(5):674-683
pubmed: 28117112
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Cancer Cell. 2013 Feb 11;23(2):159-70
pubmed: 23410972
Bioinformatics. 2014 Sep 1;30(17):i401-7
pubmed: 25161226
Nucleic Acids Res. 2016 Jun 2;44(10):e93
pubmed: 26908654
Am J Pathol. 2012 Aug;181(2):401-12
pubmed: 22705054
Nat Genet. 2018 Oct;50(10):1463-1473
pubmed: 30262816
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Genes Dev. 1997 Nov 1;11(21):2801-9
pubmed: 9353250
Cell Death Differ. 2007 Nov;14(11):1893-907
pubmed: 17762884
Mol Oncol. 2020 Jan;14(1):129-138
pubmed: 31736271
BMC Genomics. 2012 Aug 17;13:405
pubmed: 22900683
Cell Mol Life Sci. 2016 Apr;73(8):1659-70
pubmed: 26846696
Cold Spring Harb Symp Quant Biol. 2010;75:167-77
pubmed: 21209389
Nat Med. 1998 Jul;4(7):844-7
pubmed: 9662379
Bioinformatics. 2010 Oct 1;26(19):2438-44
pubmed: 20709693
Nat Genet. 2016 Aug;48(8):838-47
pubmed: 27322546
PLoS Genet. 2012;8(7):e1002772
pubmed: 22829774
Front Microbiol. 2017 Nov 29;8:2366
pubmed: 29238336
Genes (Basel). 2016 Aug 18;7(8):
pubmed: 27548225
Eur J Cancer. 1997 Apr;33(5):787-91
pubmed: 9282118
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15726-31
pubmed: 19717459
Sci Rep. 2015 Feb 03;5:8201
pubmed: 25643913
Sangre (Barc). 1989 Feb;34(1):4-9
pubmed: 2711283
Mol Biosyst. 2008 Apr;4(4):309-14
pubmed: 18354784
Int J Colorectal Dis. 2012 Nov;27(11):1391-9
pubmed: 22438068
Cell Physiol Biochem. 2018;46(6):2215-2231
pubmed: 29734189
PLoS One. 2015 Nov 24;10(11):e0143627
pubmed: 26599758
Cell. 2009 Jan 9;136(1):175-86
pubmed: 19135898
Cancer Res. 1999 Sep 1;59(17):4175-9
pubmed: 10485449
Nat Genet. 2014 Oct;46(10):1103-9
pubmed: 25217961
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8577-82
pubmed: 16723398
Cell. 2005 Jun 17;121(6):849-58
pubmed: 15960973
J Natl Cancer Inst. 2009 Jun 16;101(12):878-87
pubmed: 19509351
Cancer Res. 2013 Aug 15;73(16):5163-8
pubmed: 23946472
Genome Res. 2014 May;24(5):869-84
pubmed: 24515121
BMC Genet. 2018 May 18;19(1):32
pubmed: 29776332
Cancers (Basel). 2021 Aug 10;13(16):
pubmed: 34439179
Bioinformatics. 2008 Jul 1;24(13):i223-31
pubmed: 18586718
J Pathol. 2013 Sep;231(1):130-41
pubmed: 23794398
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Am J Pathol. 2011 Oct;179(4):1608-15
pubmed: 21888887
Cell. 1997 Aug 22;90(4):785-95
pubmed: 9288757
Oncogene. 2022 Feb;41(7):943-959
pubmed: 34667276
Methods. 2017 Feb 1;114:60-73
pubmed: 27725304
Bioinformatics. 2010 May 1;26(9):1225-31
pubmed: 20335275
Nat Methods. 2017 Dec;14(12):1141-1152
pubmed: 29083403
Nat Genet. 2017 Mar;49(3):349-357
pubmed: 28135248
Eur Urol. 2012 May;61(5):1019-24
pubmed: 22336380
Mod Pathol. 2008 Nov;21(11):1371-8
pubmed: 18552821
Oncotarget. 2017 Sep 28;8(48):84434-84448
pubmed: 29137437
PLoS One. 2018 Feb 9;13(2):e0192742
pubmed: 29425237
Pathol Res Pract. 2018 Dec;214(12):2046-2053
pubmed: 30322808
Nucleic Acids Res. 2013 Jan;41(Database issue):D177-87
pubmed: 23161675
Mol Med. 2020 Mar 6;26(1):24
pubmed: 32143573
Medicine (Baltimore). 2021 Jan 29;100(4):e23936
pubmed: 33530195
PLoS One. 2019 Aug 12;14(8):e0217605
pubmed: 31404068
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
Science. 2005 Oct 28;310(5748):644-8
pubmed: 16254181
Nat Biotechnol. 2010 Mar;28(3):245-8
pubmed: 20212490
Bioinformatics. 2011 May 15;27(10):1447-8
pubmed: 21450710
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Mod Pathol. 2013 Jul;26(7):975-83
pubmed: 23370768
Phys Rev E. 2016 Nov;94(5-1):052315
pubmed: 27967199
Nat Genet. 2012 May 20;44(6):685-9
pubmed: 22610119
J Gene Med. 2002 Jul-Aug;4(4):397-406
pubmed: 12124982
Nature. 2000 Nov 2;408(6808):53-6
pubmed: 11081503
Mol Biol Evol. 2011 Aug;28(8):2173-83
pubmed: 21335606